Milestones 2002 / 2003

• Finalize Far East joint venture contract

• Resume Oxyglobin shipments

• Break ground on S.C. manufacturing facility

• Initiate Phase II trauma trial

• European Union filing

• Initiate Phase IIB cancer trial

• BLA response letter from FDA

Previous slide

Next slide

Back to first slide

View graphic version